← Apogee Therapeutics
What podcasts say about Apogee Therapeutics
Every statement, with the speaker, the exact quote and the moment it was said.
What experts have said about Apogee Therapeutics
2 statements · 2 positive
Apogee’s psoriasis compound could rival Sanofi’s Dupixent.
“it could be a rival to France's Sanofi and its blockbuster Dupixit”
Open the episode · Apogee-AbbVie; Regenxbio and FDA News; SpaceX DeclineListen at 1:25
AbbVie is nearing an approximately $11 billion acquisition of Apogee.
“AbbVie is closing in on a nearly $11 billion deal to buy Apogee.”
Open the episode · Arcosa and Apogee Rise; Getty JumpsListen at 1:51
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.